Study of the biosynthesis and functionality of polyphosphate in Bifidobacterium longum KABP042

doi:10.21203/rs.3.rs-2230889/v1

Download PDF

Article

Study of the biosynthesis and functionality of polyphosphate in Bifidobacterium longum KABP042

https://doi.org/10.21203/rs.3.rs-2230889/v1

This work is licensed under a CC BY 4.0 License

Journal Publication

published 08 Jul, 2023

Read the published version in Scientific Reports →

You are reading this latest preprint version

Polyphosphate (poly-P) biosynthesis in bacteria has been linked to many physiological processes and has been characterized as an interesting functional molecule involved in intestinal homeostasis. We determined the capacity for poly-P production of 18 probiotic strains mainly belonging to Bifidobacterium and former Lactobacillus genera, showing that poly-P synthesis is a strain-specific trait dependent on the availability of phosphate and the growth phase. Bifidobacteria were especially capable of poly-P synthesis and poly-P kinase (ppk) genes were identified in their genomes together with a repertoire of genes involved in phosphate transport and metabolism. In Bifidobacterium longum KABP042, the strain we found with highest poly-P production, variations in ppk expression were linked to growth conditions and presence of phosphate in the medium. Moreover, the strain produced poly-P in presence of breast milk and human milk oligosaccharide lacto-N-tetraose increased the amount of poly-P synthesized. Compared to KABP042 supernatants low in poly-P, exposure of Caco-2 cells to KABP042 supernatants rich in poly-P resulted in decreased epithelial permeability and increased barrier resistance, induction of epithelial protecting factors such as HSP27 and enhanced expression of tight junction protein genes. These results highlight the role of bifidobacteria-derived poly-P as a strain-dependent functional factor acting on epithelial integrity.

Biological sciences/Microbiology/Applied microbiology

Biological sciences/Biotechnology

Biological sciences/Microbiology

Polyphosphate (poly-P) is a linear polymer of inorganic phosphate residues (Pi). This ancient molecule can be synthesized and intracellularly accumulated in form of granules by some microorganisms ^1,2. Accumulating poly-P bacteria (mainly Proteobacteria and Actinobacteria) are used in wastewater plants to remove phosphate ³. However, poly-P biosynthesis is also an interesting trait in probiotic strains. Probiotics are live microorganisms (mainly lactobacilli and bifidobacteria) that when administered in sufficient amounts have a beneficial effect on the host health ⁴. Interestingly, probiotic-derived poly-P was discovered to confer beneficial effects by enhancing the gut barrier function which is key for intestinal homeostasis. In the gut, epithelial cells internalize probiotic-derived poly-P by endocytosis, and poly-P binds to integrin β1 activating p38 MAPK pathway which induces cytoprotective factors such as the heat shock protein HSP27. This induction prevents damage of intestinal barrier ^2,5,6. The role of poly-P in maintaining intestinal homeostasis was confirmed in mice models of colitis where poly-P administration ameliorated inflammation and epithelial injury ^5,7−9, and in a pilot trial in humans, demonstrating clinical remission in patients with refractory ulcerative colitis after poly-P administration ⁹.

Thus, poly-P-producing probiotics may have beneficial effects on the human gut by preventing and alleviating intestinal permeability and inflammation. However, the knowledge of poly-P biosynthesis capacity of probiotic species is limited. Some strains of the former genus Lactobacillus including Levilactobacillus brevis SBC8803 ⁵, Lacticaseibacillus casei BL23 ¹⁰, Lacticaseibacillus paracasei JCM1163 ⁸, Lacticaseibacillus rhamnosus CRL1505 ¹¹ and Lactiplantibacillus plantarum (type strain WCFS1 and others) ^2,12 are known to form poly-P. Some bifidobacterial strains are also suggested to biosynthesize poly-P. Bifidobacterium longum ATCC 15707 and the non-probiotic Bifidobacterium scardovii BAA-773 strains accumulated granules reminiscent of poly-P ¹³; Anand et al. ¹⁴ described strains able to remove phosphate from the medium; and Saiki et al. ⁸ measured poly-P in strains of Bifidobacterium longum, Bifidobacterium animalis, Bifidobacterium breve and Bifidobacterium bifidum species, among others.

For many bacteria poly-P synthesis pathway starts by taking up Pi from the environment through the low-affinity transport system Pit or by the high-affinity ABC-type transporter system PstSCAB. Response to Pi is regulated by two-component regulatory systems (2CRS) ¹⁵. The main enzyme for poly-P synthesis is the poly-P kinase Ppk which forms poly-P from Pi utilizing ATP. Some microorganisms harbor more than one copy of ppk gene. Exopolyphosphatases (Ppx or Ppx-GppA) hydrolyze poly-P chains and in some actinobacterial species poly-P-dependent glucokinases Ppgk use poly-P as donor for glucose phosphorylation ^3,10. These routes are less studied in probiotic species. Species of the lactobacilli group harbor a ppk gene flanked by two ppx genes ¹⁰, while bifidobacteria carry the conserved 2CRS PhoRP that controls Pi response ¹⁵, and ppk gene has been detected in B. scardovii ¹³.

Poly-P concentration usually shows an increase during logarithmic growth phase, then decreases gradually up to the stationary phase and can reach undetectable levels. Although poly-P is not actively transported, some levels can be detected extracellularly ⁸. The physiological role of poly-P remains unclear and it has been linked to stress responses such as oxidative ^10,13, acidic ^10,13,16 or osmotic stress conditions ¹⁰. It is known that Pi concentration in the medium affect poly-P formation in lactobacilli ¹⁰. Carbon and nitrogen sources are suggested to affect phosphate removal in bifidobacteria ¹⁴ and polyamines (putrescine, spermine and spermidine) increase poly-P accumulation in Escherichia coli ¹⁷. However, the effect of these and other factors is less understood.

The beneficial role of several probiotic strains is linked to the protection of the intestinal barrier ¹⁸. However, whether this effect involves the biosynthesis and action of poly-P is not well known. In this work, we studied the poly-P formation capacity of 11 distinct species of probiotics and deepened in bifidobacteria group analyzing poly-P-related genes presence and organization in genomes. In addition, we used the poly-P-producer probiotic strain B. longum KABP042 to investigate the effect of environmental Pi and whether poly-P formation is involved in protection against acidic or oxidative challenges. Since KABP042 was isolated from the faeces of a breastfed infant ¹⁹ and breast milk contains Pi ²⁰, the effect of breast milk and milk bioactive compounds including human milk oligosaccharides (HMO) and polyamines on poly-P synthesis was also investigated. Furthermore, the effect of B. longum KABP042-derived poly-P in the human intestinal barrier was assessed in vitro by measuring barrier permeability and resistance and the induction of protective factors involved in barrier integrity.

Poly-P biosynthesis by probiotic strains. Poly-P biosynthesis capacity of 18 strains belonging to 11 different probiotic species was assessed by measuring intracellular poly-P accumulation in exponential and stationary phases of the growth curve in MEI or MRSc media. In total, we evaluated 13 probiotic strains belonging to the bacterial species Bifidobacterium animalis (1), Bifidobacterium bifidum (1), Bifidobacterium breve (2), Bifidobacterium longum (4), Lacticaseibacillus rhamnosus (1), Lactiplantibacillus plantarum (1), Limosilactobacillus reuteri (1), Pediococcus pentosaceus (1) and the yeast Saccharomyces boulardii (1). Five strains with published evidence of poly-P metabolism were included as controls for comparison: B. breve JMC1273, B. longum ATCC15707, Bifidobacterium scardovii BAA773, Lacticaseibacillus paracasei JMC1163 and L. plantarum WCFS1 (Table 1).

Table 1

Strains used in this study. References of probiotic effects for probiotic strains or poly-P metabolism for control strains are indicated.
Strain	Source	Classification	Reference
Bifidobacterium animalis BB12	Commercial product	Probiotic	⁴⁵
Bifidobacterium bifidum P671	INIA-CSIC	Probiotic	⁴⁶
Bifidobacterium breve JCM1273 (DSM20091)	DSM	Control	³³
Bifidobacterium breve M16V	Commercial product	Probiotic	⁴⁷
Bifidobacterium breve P734	INIA-CSIC	Probiotic	⁴⁶
Bifidobacterium longum subsp. longum 35624	Commercial product	Probiotic	⁴⁸
Bifidobacterium longum subsp. longum ATCC15707	ATCC	Control	¹³
Bifidobacterium longum subsp. longum BB536	Commercial product	Probiotic	⁴⁹
Bifidobacterium longum subsp. longum KABP042 (CECT7894)	AB-Biotics S.A.	Probiotic	¹⁹
Bifidobacterium longum subsp. longum P132	INIA-CSIC	Probiotic	⁵⁰
Bifidobacterium scardovii BAA773 (DSM13734)	DSM	Control	¹³
Lacticaseibacillus paracasei JCM1163 (DSM20006)	DSM	Control	⁸
Lacticaseibacillus rhamnosus GG (ATCC53103)	ATCC	Probiotic	⁵¹
Lactiplantibacillus plantarum 299v	Commercial product	Probiotic	⁵²
Lactiplantibacillus plantarum WCFS1 (ATCC BAA-793)	ATCC	Control	²
Limosilactobacillus reuteri DSM17938	Commercial product	Probiotic	⁵³
Pediococcus pentosaceus KABP041 (CECT8330)	AB-Biotics S.A.	Probiotic	¹⁹
Saccharomyces boulardii CNCM I-745	Commercial product	Probiotic	⁵⁴
CECT, Spanish Type Culture Collection; ATCC, American Type Culture Collection; DSM, German Collection of Microorganisms and Cell Cultures; INIA-CSIC, National Institute for Agricultural and Food Research and Technology (Spain).

Strains were first cultured in MEI medium which allows a higher poly-P formation compared with MRSc probably due to its high concentration of phosphate (Alcántara et al., 2014). However, some bifidobacteria strains failed to grow in this medium and were cultured in MRSc instead. Bifidobacteria strains able to grow in MEI were also cultured in MRSc for comparison (Fig. 1). OD values varied between strains (Supplementary Table S1) and thus poly-P amounts were normalized to OD.

In general, bifidobacteria strains accumulated greater amounts of poly-P than lactobacilli strains while poly-P detected in P. pentosaceus and S. boulardii was very low (Fig. 1a and Supplementary Table S1). Nevertheless, poly-P values varied greatly between strains and were generally higher at 6 h than 16 h of growth except for B. animalis BB12 and B. breve M16V which accumulated more at 16 h (Fig. 1a and 1b), indicating poly-P accumulation depends on the strain and fluctuates with the growth curve.

Among strains of the former Lactobacillus genus, control strains L. paracasei JMC1163 and L. plantarum WCFS1 showed the greater poly-P values while the other strains accumulated very low amounts (Fig. 1a and Supplementary Table S1). All bifidobacteria strains were able to accumulate some poly-P amount but the quantity was very low in B. bifidum P671 and the control strain B. scardovii BAA773 (Fig. 1b). Notably, B. longum strains showed the greater poly-P biosynthesis capacity, suggesting that this trait is conserved in the species. Interestingly, B. longum KABP042 accumulated the highest levels during both exponential and stationary growth phases and was the only strain showing this profile. As expected, levels of poly-P were generally lower in MRSc than MEI medium for those bifidobacteria able to grow in both media, despite they reached higher OD values in MRSc (Fig. 1a, 1b and Supplementary Table S1). These outcomes confirm MEI medium permits a greater poly-P synthesis and strains can biosynthesize poly-P with high capacity despite showing low growth.

In silico search of poly-P kinase ppk gene was carried out in the available genomes of the studied strains. Gene ppk was not found in P. pentosaceus KABP041 strain which concordantly showed very low poly-P levels. Consistently with phenotypic results, all bifidobacterial genomes harbor the gene, suggesting it is a spread trait among bifidobacteria (Table 2). Nevertheless, variation in poly-P levels between strains suggest different regulation mechanisms must be involved in poly-P biosynthesis.

Table 2

Identification of *ppk* gene in the available genomes of studied strains by BLAST. Genomes were obtained from NCBI except ATCC15707 genome which was obtained from the American Type Culture Collection (ATCC). Genomes not included in the analysis were not available in any public database. Percent identity as calculated against reference genomes: *B. longum* NCC2705 for bifidobacterial *ppk* and *L. plantarum* WCSF1 for lactobacilli *ppk*.
Strain	Genome accession no.	Reference Genome	ppk identity (%)
B. animalis BB12	NC_017214.2	AE014295.3	82
B. bifidum P671	JAPFGE000000000	AE014295.3	84
B. breve P734	NZ_CABFNK000000000.1	AE014295.3	93
B. longum 35624	CP013673.1	AE014295.3	99
B. longum ATCC15707	GCA_000196555.1	AE014295.3	98
B. longum KABP042	JAHTKJ000000000.1	AE014295.3	99
B. scardovii BAA773	AP012331.1	AE014295.3	85
L. rhamnosus GG	FM179322.1	NC_004567.2	64
L. plantarum WCFS1	NC_004567.2	NC_004567.2	100
P. pentosaceus KABP041	JAHTMM000000000.1	NC_004567.2	ND
ND, not detected

Organization of poly-P-related genes in bifidobacteria. We further investigate the presence of other poly-P-related genes and their organization in the genomes of bifidobacterial strains. Nucleotide sequences of poly-P-related genes of B. longum BXY01 were used as template in the in silico analyses because this genome contains all genes of interest. These included the two-component regulatory system (2CRS) phoRP, the high-affinity phosphate ABC-type transporter pstSCAB, the low-affinity Pi-specific transporter pit, the poly-P-dependent glucokinase ppgk, the exopolyphosphatase ppx-gppA and the poly-P kinase ppk (Alvarez-Martin et al., 2012; Kawakoshi et al., 2012).

As shown in Fig. 2 and Table 2, all bifidobacterial strains investigated harbored the poly-P kinase ppk gene, but the distribution of the rest of associated genes varied greatly between strains. Similar to B. longum BXY01, B. longum strains KABP042, ATCC15707 and 35624 displayed almost identical gene repertoire except for the low-affinity phosphate transporter pit, which was absent in their genomes. Genome of B. breve P734 contained a truncated 2CRS lacking the membrane-associated histidine protein kinase gene phoR. This genome also lacked the poly-P-dependent glucokinase ppgk, but one copy of the transport protein pit was detected. In the genome of B. bifidum P671 the membrane-associated histidine kinase phoR and the phosphate transporter pit were not identified, and the exopolyphosphatase gene ppx-gppA was truncated. In the genome of B. scardovii BAA773, only the high-affinity ABC-type transporter pstSCAB was detected, apart from the ppk gene. Finally, only the pstA and the ppk genes were identified in the genome of B. animalis BB12.

Synthesis of poly-P and ppk expression in B. longum KAPB042

Since B. longum KAPB042 was the highest poly-P producer within the probiotics tested, we decided to study its poly-P synthesis capacity in more detail. Growth and poly-P accumulation in this strain was assayed under high (MEI medium) or low Pi conditions (LP-MEI medium). Growth attained under low Pi was lower (p < 0.05 for 6, 16 and 24 h; Fig. 3a). The amount of poly-P accumulated inside the cells was higher under high Pi compared to low Pi conditions and it suffered a reduction at late stationary phase (p < 0.001 for 6, 16 and 24 h; Fig. 3b). It was also observed that the amount of poly-P in growth supernatants was low compared to intracellular poly-P, showing that a small proportion of synthesized poly-P is excreted outside the bacteria. Poly-P amounts were greater in supernatants from MEI cultures than LP-MEI mirroring the profile inside the cells (p < 0.01 for 16 and 24 h; Fig. 3b). Expression of ppk in B. longum cells was higher for cells grown in MEI compared to LP-MEI at late growth phase (16 h, p < 0.001; Fig. 3c), while differences at other time points of the growth curve were low, suggesting a relative impact of Pi availability in the modulation of ppk expression. In addition, we confirmed the presence of poly-P granules in these cells, which showed the characteristic intracellular inclusions after specific staining. Granule numbers and density were also higher in MEI compared to LP-MEI (Supplementary Fig. 1).

B. longum KAPB042 biosynthesized poly-P in presence of breast milk and accumulation is affected by the consumed HMO LNT but not by polyamines.

B. longum is a typical inhabitant of the intestinal tract of breast-fed infants. Specifically, the strain KABP042 originated from feces of a breastfed infant and is known to exert beneficial effects in lactating infants with colic ¹⁹. Because B. longum and human milk interact in the infant gut we tested the effect of breast milk (which is known to contain around 4.5 mM Pi ²⁰) and specific milk components on poly-P synthesis in the KAPB042 strain. Previous studies have suggested carbon source and polyamines can impact bacterial poly-P metabolism ^14,17, thus we decided to study the effect of human milk oligosaccharides (HMO) which are known to be specifically consumed by some bifidobacteria ²¹ and the effect of polyamines at levels found in breast milk. Since there are over 200 different HMO structures in human milk ²¹ we first studied the HMO-metabolizing capacity of B. longum KABP042.

The genome of B. longum KABP042 was first screened for the presence of carbohydrate metabolizing enzymes through eggNOG mapper ²² and dbCAN annotation tools ²³. In silico analyses revealed the presence of 86 Carbohydrate Active enZYmes (CAZy), of which 58 were glycoside hydrolases (GH), and 26 glycosyl transferases (GT). Among GH enzymes, most common families were GH43 and GH13, which are involved in the degradation of a wide range of carbohydrates, including plant-derived polysaccharides ^24,25. Further analyses indicated KABP042 harbors genes encoding HMO-degrading enzymes including the lnbXY locus (lacto-N-biosidase), which specifically degrades the HMO lacto-N-tetraose (LNT) ²⁶, in addition to beta-galactosidase, alpha-galactosidase and beta-glucuronidase genes. In this line, in vitro experiments showed the strain grows in medium with LNT as unique carbon source (Supplementary Fig. 2), confirming B. longum KABP042 can utilize the HMO LNT. Therefore, we studied the effect of this specific HMO on poly-P biosynthesis. The ability to synthesize poly-P in KABP042 was determined in medium MEI supplemented with different carbon sources (human milk, LNT or glucose as control) and in MEI containing the polyamines putrescine, spermidine and spermine. Although growth in the presence of human milk was low under our experimental conditions (p < 0.0001 for all time points), the levels of poly-P were similar to those obtained with glucose during the first stage of growth (Fig. 4a and 4b). Growth in MEI with LNT as carbon source was lower compared to glucose (p < 0.0001 at 6 h; Fig. 4a), but it resulted in high contents of intracellular poly-P, that remained for a longer period (p = 0.008, 0.0006 and 0.007 for 6, 16 and 20 h, respectively; Fig. 4b). The presence of polyamines in MEI had low effects on the maximal amount of poly-P, although their levels diminished slower compared to control. In these new experiments the amount of poly-P detected in KABP042 was noticeably lower compared to the previous measurements. We have noticed this effect when batches of complex MEI components were renewed, suggesting a strong effect of medium composition on poly-P yields. The expression of ppk was measured under these conditions (Fig. 4c). Compared to growth in MEI with glucose, growth with added breast milk resulted in enhanced ppk expression during early exponential phase concordantly with poly-P production, while the presence of polyamines resulted in increased expression at 16 h but these changes did not reach statistical significance LNT did not affect ppk expression despite the observed differences in poly-P biosynthesis. No differences were observed in late stationary cells between the different growth conditions. These outcomes suggest B. longum KABP942 may synthesize poly-P in presence of breast milk and the HMO LNT enhances the production. Although some breast milk components may affect ppk expression other post-transcriptional regulatory mechanisms seem to be involved in poly-P metabolism.

Poly-P derived from B. longum KABP04 increases the integrity of the intestinal barrier and reduces permeability by upregulating the production of HSP27 and the expression of tight junction proteins. Probiotic-derived poly-P has been shown to play roles in intestinal cytoprotection and host cell survival under stress conditions, protecting the gut barrier ^5–8. We tested this point by measuring whether Caco-2 cells monolayers exposed to neutralized supernatants of B. longum KABP042, grown under high or low Pi conditions, at the apical side of Transwell inserts presented changes in the functionality of the cellular barrier. As can be seen in Fig. 5a, the TEER in cultures exposed to B. longum KABP042 growth supernatants (10% v/v; conditioned medium) carrying high poly-P (grown in MEI, Fig. 3b) was significantly higher compared to culture supernatants with low poly-P contents (grown in LP-MEI) (p = 0.001). Consistently, permeability (P_app) to Lucifer Yellow dye was significantly lower in cells exposed to MEI conditioned by B. longum KABP042 (Fig. 5b) compared to conditioned LP-MEI (p = 0.01). These outcomes suggest poly-P produced by B. longum KABP042 can exert a protective effect on the gut barrier by increasing resistance and reducing permeability of the monolayer.

In order to investigate the mechanisms involved in the protection of the intestinal epithelium by B. longum KABP042-derived poly-P, we measured expression of genes encoding proteins from the tight junctions (ZO1, JAM1 and OCLN) that are crucial for the maintenance of the barrier integrity ²⁷. The presence of conditioned MEI medium resulted in higher gene expression for JAM-1 (p = 0.008) and OCLN (p = 0.0093) in Caco-2 cells (Fig. 5c), indicative of a stronger functional barrier. We also determined the levels of HSP27, which is known to be modulated by poly-P produced by some lactobacilli ⁵. The intestinal epithelial cell line Caco-2 was exposed to B. longum KABP042 growth supernatants from cultures in MEI and LP-MEI. Addition of fresh MEI or LP-MEI to the cultures (control) showed no differences in HSP27 induction; however, conditioned MEI or LP-MEI showed differences in HSP27 levels, with MEI supernatants displaying a significantly higher HSP27 relative expression (p < 0.0001) (Fig. 6a and 6b). Furthermore, a significant correlation was also observed between HSP27 expression and poly-P amounts in supernatants of B. longum (Pearson r = 0.87, p = 0.01) (Fig. 6c). Altogether, these data suggest that poly-P derived from B. longum KABP042 has a positive effect on intestinal homeostasis.

The study of poly-P production in lactobacilli, bifidobacteria and probiotics in general received low attention until this molecule was reported as a functional bacterial metabolite ¹⁰. Since then, probiotic-derived poly-P has been characterized as a beneficial molecule that protects against intestinal injury ^7,9, but additional functions in preventing inflammatory processes at different locations are also being reported ^28,29. In this study, we show that, under the tested conditions with our collection of probiotics, production of poly-P was a strain-dependent characteristic. Notwithstanding strain specificity bifidobacteria, especially B. longum subsp. longum, were among the best producers.

As occurred with lactobacilli ¹⁰, poly-P production in bifidobacteria was linked to the presence of ppk gene. Different than lactobacilli ^1,10, ppk and ppx genes are not organized in an operon in bifidobacteria. The presence of elevated amounts of Pi was the principal factor affecting poly-P accumulation in the assayed strains, as previously showed in lactobacilli ¹⁰. A repertoire of genes involved in Pi uptake (pst and pit genes) was also found in bifidobacteria, a factor known to influence poly-P storage ^30,31. However, it is not known at this stage whether the presence of such complement of genes has any impact on the capacity of a certain Bifidobacterium strain to accumulate poly-P. An extensive variability exists within Bifidobacterium spp. in relation to the distribution of these poly-P-related genes, especially the pit gene. This again suggests that some traits are species- and strain-specific. B. longum strains display the maximum number of poly-P-associated genes. These observations were in line with the in vitro experiments, since B. longum strains were those producing greater levels of poly-P. On the contrary, B. animalis BB12 also accumulated high levels of poly-P despite harboring the lesser number of these genes. Further research should be conducted to determine the role of these and putative additional genes in the poly-P synthesis and accumulation in bifidobacteria.

Besides of Pi availability in the medium, the conditions that govern poly-P levels in bifidobacteria are unclear. The sharp drop of intracellular poly-P levels at the onset of stationary phase in L. paracasei JCM 1163 ⁸ suggests that poly-P plays an active role during the physiology of stationary cells. In the case of B. longum KABP042 poly-P concentration remained high during early stationary phase. It is postulated that poly-P levels in cells are governed by the opposite activities of Ppk (poly-P forming) and Ppx (poly-P degrading) enzymes ³², while gene regulation would have a minor impact (as mentioned, ppk and ppx are cotranscribed in a large number of bacteria). However, we showed that in B. longum KABP042 expression of ppk was favored by growth with high levels of Pi at early stationary phase, but it also suffered variations depending on other growth conditions, such as the presence of human milk. On the contrary, although consumption of the HMO LNT by B. longum KABP042 increased the biosynthesis of poly-P, the expression of ppk was not affected indicating other regulatory mechanisms are involved. Further studies are warranted to understand this result as it represents an interesting synergic effect for breasted infants administered with this probiotic strain. Although Anand et al. ³³ have suggested that carbon sources such as fructooligosaccharides influence phosphate metabolism in bifidobacteria, this is the first time the effect of breast milk and HMO in poly-P biosynthesis is investigated. In this regard, HMO consumption by bifidobacteria has sometimes been treated as a desirable trait per se to facilitate intestinal colonization, but may in fact be just a means to an end: the actual production of bacterial biomolecules supporting the homeostasis of the host.

The maintenance of intestinal barrier integrity is one of the many attributes of probiotics and the interaction with several cellular pathways have been evidenced for this effect ³⁴. Poly-P has emerged as a functional molecule produced by probiotics which acts in this sense ^5,6,8. We showed that, as reported in other strains ^2,5, supernatants of B. longum KABP042 conferred strengthening of the intestinal barrier in the Caco-2 cell model by upregulating HSP27, but also by having an effect on the expression of tight junction proteins genes, which most probably results in the reduced permeability that was found in this model when exposed to B. longum KABP042 supernatants. Of note, reduced permeability was not observed by treating Caco-2 cells with fresh MEI medium, indicating the effect is not due simply to high Pi content. Poly-P derived from L. paracasei JCM 1163 was also shown to reduce permeability in mice small intestine explants exposed to oxidants ⁸ and the mechanism for this was hypothesized to be dependent on TNFAIP3 induction, a factor involved in cytokine-mediated immune and inflammatory responses and which increases intestinal barrier function via modulation of tight junction proteins ⁶.

Although the differences that we observed in Caco-2 cells after incubation with conditioned MEI or LP-MEI supernatants were most probably linked to differences in poly-P levels between both cultures, strains unable to synthesize poly-P are needed to ascertain this point. Such knockout mutants in the ppk gene were obtained for two strains of L. plantarum, where the involvement of poly-P synthesis in HSP27 induction was verified ². The variations observed while using growth supernatants with high or low Pi implies that the growth conditions or the environment where the probiotic develops will have an impact on its functional properties, as already reported ^35,36. In fact, we showed that in B. longum KABP042, isolated from breastfed infant feces, the presence of breast milk or other human milk components such as LNT impacted poly-P yields.

Some potential limitation for the application of poly-P producing bifidobacteria are the fluctuations in the levels of the polymer synthesis, and the fact that poly-P is a cytoplasmic molecule in bacteria, but its beneficial activity seems to require extracellular presence. Our results as well as those from a previous publication with mutant strains from L. paracasei JCM 1163 indicate that extracellular poly-P represents a low proportion of the polymer found inside the cells ⁸. Poly-P is most probably not actively excreted to the growth medium and its presence outside the cells could be a mere effect of cell leakage, cell lysis or poly-P present as part of extracellular vesicles ³⁴. Accordingly, higher intracellular accumulation would be expected to also result in higher extracellular levels, even if the later remain a fraction of the former. In this regard, our results show that accumulation kinetics of extracellular poly-P grows across time, possibly following accumulation of intracellular one. Of note, extracellular poly-P levels produced by KABP042 were enough to exert significant effects in the gut barrier, as demonstrated in our experiments. Nevertheless, screening/construction of bifidobacterial strains with high/enhanced poly-P synthesis and, if possible, increased poly-P excretion, could constitute a valuable strategy to study poly-P functionality and to obtain new candidate probiotics.

In conclusion, we showed that probiotic bifidobacteria may be good producers of poly-P, although the synthesis of this molecule is strain-specific and fluctuates depending on the growth conditions. Bifidobacterial-derived poly-P represents a probiotic factor able to protect the epithelial integrity and its synthesis could be included in strain screening and selection processes.

Strains and culture conditions.

Strains used in this study and their sources are indicated in Table 1. To isolate strains from commercial products, capsule content was resuspended in medium and plated on agar plates. Single colonies were obtained and grown to prepare glycerol stocks. Species identity was confirmed by PCR amplification and sequencing of the 16S rRNA gene.

Routine medium was MRS for lactobacilli and Pediococcus pentosaceus, MRS supplemented with 0.1% (w/v) cysteine-HCl (MRSc) for bifidobacteria, and YDP medium for Saccharomyces boulardii. The strains were cultured at 37°C under anaerobic conditions except S. boulardii which was cultured aerobically. For poly-P production assay, MEI medium was used ² (per liter: 0.5% yeast extract, 0.5% tryptone, 0.4% K₂HPO₄, 0.5% KH₂PO₄, 0.02% MgSO₄·7H₂O, 0.005% MnSO₄, 0.05% cysteine, and 0.5% glucose (w/v) and 1 ml of Tween 80). A low-phosphate MEI medium (LP-MEI) was formulated without the addition of K₂HPO₄, and KH₂PO₄.

In silico analysis.

Nucleotide sequences for ppk gene were retrieved from the NCBI from reference genomes AE014295.3 (B. longum NCC2705) and AL935263.2 (L. plantarum WCFS1) respectively, and subjected to BLAST analysis ³⁷ against available genomes of studied strains. Genome accession numbers are indicated in Table 1. To study other polyP-related genes and their organization in bifidobacterial strains, genome sequence of B. longum BXY01 was retrieved from the NCBI (accession number CP008885.1) and nucleotide sequences of genes phoR, phoP, pstS, pstC, pstA, pstB, pit, ppgK, ppx-ggpA and ppk were used as reference. Genome sequences of Bifidobacterium spp. strains were inspected for the presence of polyP-related genes using BLAST (Altschul et al., 1990).

To identify genes related to carbohydrate metabolism including HMOs, the genome of B. longum KABP042 was annotated using eggNOG v.4.5.1 platform ²² and the specific detection of carbohydrate active enzymes was performed using the dbCAN automated CAZy annotation meta server ²³.

Polyphosphate granules staining.

Observation of poly-P granules accumulated in B. longum KABP042 as a function of growth was performed by harvesting the bacteria after growing them in 15 ml of MEI or LP-MEI medium at 37°C under anaerobic conditions at different points of the growth curve (3, 6, 16 and 24 h of culture). Bacterial smears on microscope slides were air dried, and poly-P granules were specifically stained by the procedure of Neisser ³⁸ with methylene blue/crystal violet and chrysoidin G as previously described ¹⁰.

Polyphosphate isolation and quantification.

Analysis of poly-P accumulation in bacterial strains as a function of growth was performed by harvesting the bacteria and supernatants after growing the different strains in 15 ml of liquid MEI, LP-MEI or MRSc medium at 37°C at different points of the growth curve (3, 6, 16 and 24 h). Poly-P was isolated by its resistance to hydrolysis with hypochlorite ³⁹ as previously described ¹⁰. Briefly, bacterial cells were collected by centrifugation and lysed in 1 ml of 5% sodium hypochlorite. Insoluble material was pelleted by centrifugation at 16000 x g and washed twice with 1 ml of 1.5 M NaCl/1 mM EDTA. Poly-P was extracted from the pellets with water, precipitated with NaCl and ethanol, and resuspended in 50 µl of water.

The extracellular contents of poly-P were determined as previously described ² by fluorescence using 4´,6´ diamino-2-fenilindol (DAPI) at a final concentration of 10 µM in 50 mM Tris-HCl pH 7.5, 50 mM NaCl buffer with an excitation wavelength of 415 nm and emission at 550 nm ⁴⁰ in a Clariostar fluorimeter (BMG LabTech). A sample of poly-P isolated from B. longum KABP042 was hydrolyzed with a volume of 2 M HCl and incubation at 95°C, 15 min, followed by neutralization by adding half volume of 2 M NaOH. The released phosphate was measured with the Biomol Green kit (Enzo Life Sciences) and this quantified sample was used to build a standard curve for quantification using DAPI.

ppk gene expression.

Four reference genes (16S rDNA, tufA, rpoB, and atpD ⁴¹) were selected to normalize the expression of polyphosphate kinase target gene (ppk). Based on the B. longum JCM 1217 genome sequence (Genbank accession number AP010888), primer sequences were designed for ppk and the four reference genes in order to generate amplicons ranging from 50 to 100 bp in size (see Supplementary Table S2). Total RNA was isolated from B. longum with TRIzol method as described previously ⁴². RNA samples were treated with the Ambion Turbo DNA-free™ kit (Applied Biosystems) and first-strand cDNA was synthesized from 5 µg RNA using the SuperScript VILO cDNA synthesis kit (Invitrogen). Real-time qPCR was performed using the LightCycler®480 Real-Time PCR system (Roche Diagnostics, USA) with cDNA samples diluted 1/10 in duplicate and the LightCycler® 480 SYBR Green I Master Mix (2X, Roche). The cycling conditions were as follows: 95°C for 10 min, followed by 40 cycles of three steps consisting of denaturation at 95°C for 10 s, primer annealing at 50°C for 10 s, and primer extension at 72°C for 20 s. Relative gene expression was calculated using the Relative Expression Software Tool (REST 2006, Qiagen).

Tight junction protein gene expression.

Caco-2 cells were seeded in 12-well plates at a density of 8 × 10⁴ cells/cm², and after reaching confluence (10 days), they were exposed for 16 h to diluted supernatant medium of B. longum KABP042 cultured for 16 h in MEI and LP-MEI medium. After exposure, the cells were recovered with 250 µl of TRIzol and RNA was extracted, quantified spectroscopically using a NanoDrop ND-1000 system (NanoDrop Technologies, USA) and treated with DNaseI. cDNA was obtained from 5 µg of total RNA using SuperScript VILO cDNA synthesis kit (Invitrogen). qPCR was performed using the LightCycler® 480 Real-Time PCR system (Roche Diagnostics, USA). Reactions were carried out in a final volume of 10 µL containing 5 µL LightCycler® 480 SYBR Green I Master Mix (2X, Roche), 1 µL cDNA (35 ng/µl), 1 µL of each forward and reverse primer (10 µM), and nuclease-free water. 18S ribosomal RNA and GADPH were employed as reference genes. The oligonucleotides employed are shown in Supplementary Table S1. The qPCR conditions were 95°C for 5 min, followed by 40 cycles: 10 s denaturation at 95°C, 10 s annealing at 55°C, and 20 s elongation at 72°C.

Growth of the strain in the presence of breast milk, HMO (lacto- N -tetraose; LNT) and polyamines.

Optical density, pH, extracellular and intracellular contents of poly-P and expression of the ppk gene were determined for B. longum KABP042 at 6, 16 and 24 h of growth. The experiment was carried out in anaerobic jars, incubating the bacteria in 4 ml of MEI medium (control) or MEI medium in which glucose was replaced by 1% LNT or 1% (v/v) of a pool of four human milks and in MEI with a mixture of three polyamines at concentrations found in human milk (70.0, 424.2 and 610.0 10 nmol/dl for putrescine, spermidine and spermine, respectively ⁴³. Breast milk samples were obtained from 4 healthy women. The study was approved by the local ethics committee of Atención Primaria-Generalitat Valenciana (CEIC-APCV, registry 8108, approval 26/01/2017). All participants provided written informed consent and all experiments were performed in accordance with relevant guidelines and regulations.

Quantification of HSP27 expression.

Quantification of HSP27 in the human colon carcinoma Caco-2 cells line was performed as described ². Briefly, B. longum KABP042 strain was grown for 16 h in MEI and LP-MEI medium and the supernatants (conditioned media) were obtained by centrifugation at 6000 X g for 10 min followed by filtration through 0.2 mm pore-size filters. Caco-2 cells were seeded at 8 × 10⁴ cells per well in 24-well culture plates with Minimum Essential Medium supplemented with 10% (v/v) fetal bovine serum and 1% (v/v) sodium pyruvate, 1% (v/v) non-essential amino acids, 10 mM HEPES, 0.0025 mg/L Fungizone and 100 U/ml Penicillin (cMEM) and incubated at 37°C in an atmosphere with 95% relative humidity and 5% CO₂, until confluence (10 days), with medium changes every 2–3 days. Bacterial supernatants (three independent cultures) were neutralized with NaOH solution and diluted 1:10 in cMEM medium. One milliliter aliquots of each diluted replicate were added to the cell cultures and incubation proceeded for 16 h. Cells from the wells were lysed by adding 50 µl of SDS-PAGE loading buffer per well and boiling prior separation in 12.5% SDS-PAGE gels. Proteins were transferred to Hybond ECL nylon membranes (GE Healthcare) and probed with rabbit polyclonal anti-HSP27 serum (Sigma) or with mouse monoclonal anti-β-actin antibody (Sigma).

Caco-2 monolayer integrity.

Integrity of Caco-2 cell monolayers was evaluated by measuring transepithelial electrical resistance (TEER) and the apparent permeability coefficients (P_app) of the paracellular transport marker Lucifer Yellow (LY; Sigma). The assays were carried out in 12-well plates with polyester membrane inserts (pore size 0.4 µm, Transwell®, Costar Corporation, Sigma). The cells were seeded (5×10⁴ cells/cm²) on the apical side to produce a cell monolayer. Then, 0.5 mL of cMEM was added to the apical chamber, and 1.5 ml of the same medium was added to the basolateral chamber. The cells were maintained in a humidified atmosphere of 5% CO₂ and 95% air at 37°C, with a change of medium every 2–3 days until differentiation (7–8 days post-seeding). During cell differentiation in the bicameral systems the TEER was measured with a Millicell®-ERS voltohmmeter (Millipore Corporation) to evaluate the progress of the monolayers. Once the monolayer was reached, the cells were treated with 0.5 ml of MEM medium containing 10% volume of supernatants from the growth of B. longum for 16h in MEI or LP-MEI medium. After 72 h of treatment, TEER and permeability to LY were determined as described ⁴⁴

Statistical analysis.

All tests were performed in at least three independent cultures. The results were subjected to statistical analysis by one-factor analysis of variance (ANOVA) with Sidak post hoc multiple comparisons, two-factor ANOVA with Dunnett or Sidak post hoc multiple comparison, or by Student's t-test, according to design of each experiment (number of groups and presence or not of time factor), while correlation was assessed by Pearson test. All tests were performed with GraphPad Prism v8.0. Differences were considered significant at two-sided p < 0.05.

Acknowledgements

The authors gratefully acknowledge the financial support of this work by the Center for the Development of Industrial Technology (CDTI) of the Spanish Ministry of Science and Innovation (project number IDI-20220028). The authors thank Inbiose (Belgium) for the donation of the HMO sample used in this study, Dr. MC Collado for providing milk samples and Pilar Rodríguez-Viso for her help in the Transwell experiments.

Author contributions

CA performed most of the experimental work. PH, TA and JLA carried out some of the experiments. MP, VM, MZ and JE-M conceived the idea. VM and MP participated in data interpretation and wrote the manuscript. All authors approved the final manuscript.

Data availability

All data generated or analysed during this study are included in this published article (and its Supplementary Information files) or are available upon request to corresponding author.

Additional Information

Competing interest: PH, TA, MP and JE-M are employees of AB-Biotics S.A. (part of KANEKA Corporation). The isolates described in this study are the subject of a pending patent application co-authored by MP and JE-M. The remaining authors have no conflict of interest to declare.

Rao, N. N., Gómez-García, M. R. & Kornberg, A. Inorganic polyphosphate: essential for growth and survival. Annual review of biochemistry. 78, 605–647. doi:10.1146/ANNUREV.BIOCHEM.77.083007.093039 (2009).
Alcántara, C. et al. Polyphosphate in Lactobacillus and its link to stress tolerance and probiotic properties. Frontiers in Microbiology. 9. doi:10.3389/fmicb.2018.01944 (2018).
Kawakoshi, A. et al. Deciphering the Genome of Polyphosphate Accumulating Actinobacterium Microlunatus phosphovorus. DNA Research. 19, 383–394. doi:10.1093/dnares/dss020 (2012).
Hill, C. et al. Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nature reviews. Gastroenterology & hepatology. 11, 506–514. doi:10.1038/nrgastro.2014.66 (2014).
Segawa, S. et al. Probiotic-Derived polyphosphate enhances the epithelial barrier function and maintains intestinal homeostasis through integrin-p38 MAPK pathway. PLoS ONE. 6. doi:10.1371/journal.pone.0023278 (2011).
Tanaka, K. et al. Probiotic-derived polyphosphate improves the intestinal barrier function through the caveolin-dependent endocytic pathway. Biochemical and Biophysical Research Communications. 467, 541–548. doi:10.1016/j.bbrc.2015.09.159 (2015).
Kashima, S. et al. Polyphosphate, an active molecule derived from probiotic Lactobacillus brevis, improves the fibrosis in murine colitis. Translational Research. 166, 163–175. doi:10.1016/j.trsl.2015.02.002 (2015).
Saiki, A. et al. A < i > Lactobacillus</i > mutant capable of accumulating long-chain polyphosphates that enhance intestinal barrier function. Bioscience, Biotechnology, and Biochemistry. 80, 955–961. doi:10.1080/09168451.2015.1135041 (2016).
Fujiya, M. et al. Long-Chain Polyphosphate Is a Potential Agent for Inducing Mucosal Healing of the Colon in Ulcerative Colitis. Clinical Pharmacology and Therapeutics. 107, 452–461. doi:10.1002/cpt.1628 (2020).
Alcántara, C., Blasco, A., Zúñiga, M. & Monedero, V. Accumulation of polyphosphate in Lactobacillus spp. and its involvement in stress resistance. Applied and Environmental Microbiology. 80, 1650–1659. doi:10.1128/AEM.03997-13 (2014).
Correa Deza, M. A. et al. Inorganic salts and intracellular polyphosphate inclusions play a role in the thermotolerance of the immunobiotic Lactobacillus rhamnosus CRL 1505. PLoS ONE. 12. doi:10.1371/journal.pone.0179242 (2017).
Perez, M. et al. Derived Postbiotics of a Multi-strain Probiotic Formula Clinically Validated for the Treatment of Irritable Bowel Syndrome. The FASEB Journal. 34, 1. doi:doi:10.1096/fasebj.2020.34.s1.05062 (2020).
Qian, Y., Borowski, W. J. & Calhoon, W. D. Intracellular granule formation in response to oxidative stress in Bifidobacterium. International Journal of Food Microbiology. 145, 320–325. doi:10.1016/j.ijfoodmicro.2010.11.026 (2011).
Anand, A. & Aoyagi, H. Estimation of microbial phosphate-accumulation abilities. Scientific Reports. 9, 1–9. doi:10.1038/s41598-018-37752-8 (2019).
Alvarez-Martin, P. et al. A conserved two-component signal transduction system controls the response to phosphate starvation in Bifidobacterium breve UCC2003. Applied and environmental microbiology. 78, 5258–5269. doi:10.1128/AEM.00804-12 (2012).
Jin, J. et al. Mechanism Analysis of Acid Tolerance Response of Bifidobacterium longum subsp. longum BBMN 68 by Gene Expression Profile Using RNA-Sequencing. PLoS ONE. 7, e50777. doi:10.1371/journal.pone.0050777 (2012).
Motomura, K., Takiguchi, N., Ohtake, H. & Kuroda, A. Polyamines Aff ect Polyphosphate Accumulation in Escherichia coli. Journal of Environmental Biotechnology. 6, 41–46. 2006).
Mennigen, R. & Bruewer, M. Effect of Probiotics on Intestinal Barrier Function. Annals of the New York Academy of Sciences. 1165, 183–189. doi:10.1111/J.1749-6632.2009.04059.X (2009).
Astó, E. et al. Probiotic Properties of Bifidobacterium longum KABP042 and Pediococcus pentosaceus KABP041 Show Potential to Counteract Functional Gastrointestinal Disorders in an Observational Pilot Trial in Infants. Frontiers in Microbiology. 12, 4321. doi:10.3389/FMICB.2021.741391/BIBTEX (2022).
Sabatier, M. et al. Longitudinal changes of mineral concentrations in preterm and term human milk from lactating swiss women. Nutrients. 11. doi:10.3390/nu11081855 (2019).
Sakanaka, M. et al. Varied Pathways of Infant Gut-Associated Bifidobacterium to Assimilate Human Milk Oligosaccharides: Prevalence of the Gene Set and Its Correlation with Bifidobacteria-Rich Microbiota Formation. Nutrients. 12. doi:10.3390/nu12010071 (2019).
Huerta-Cepas, J. et al. eggNOG 4.5: a hierarchical orthology framework with improved functional annotations for eukaryotic, prokaryotic and viral sequences. Nucleic Acids Res. 44, D286-293. doi:10.1093/nar/gkv1248 (2016).
Zhang, H. et al. dbCAN2: a meta server for automated carbohydrate-active enzyme annotation. Nucleic Acids Res. 46, W95-W101. doi:10.1093/nar/gky418 (2018).
Arboleya, S. et al. Gene-trait matching across the Bifidobacterium longum pan-genome reveals considerable diversity in carbohydrate catabolism among human infant strains. BMC Genomics. doi:10.1186/s12864-017-4388-9 (2018).
Milani, C. et al. Bifidobacteria exhibit social behavior through carbohydrate resource sharing in the gut. Sci Rep. 5, 15782. doi:10.1038/srep15782 (2015).
Sakurama, H. et al. Lacto-N-biosidase encoded by a novel gene of bifidobacterium longum subspecies longum shows unique substrate specificity and requires a designated chaperone for its active expression. Journal of Biological Chemistry. 288, 25194–25206. doi:10.1074/jbc.M113.484733 (2013).
Vancamelbeke, M. & Vermeire, S. The intestinal barrier: a fundamental role in health and disease. Expert Rev Gastroenterol Hepatol. 11, 821–834. doi:10.1080/17474124.2017.1343143 (2017).
Correa Deza, M. A. et al. Inorganic polyphosphate from the immunobiotic Lactobacillus rhamnosus CRL1505 prevents inflammatory response in the respiratory tract. Saudi J Biol Sci. 28, 5684–5692. doi:10.1016/j.sjbs.2021.06.010 (2021).
Takauji, S. et al. Polyphosphate, Derived from Lactobacillus brevis, Modulates the Intestinal Microbiome and Attenuates Acute Pancreatitis. Dig Dis Sci. 66, 3872–3884. doi:10.1007/s10620-020-06747-9 (2021).
Kuroda, A. & Ohtake, H. Molecular analysis of polyphosphate accumulation in bacteria. Biochemistry (Mosc). 65, 304–308. 2000).
Morohoshi, T. et al. Accumulation of inorganic polyphosphate in phoU mutants of Escherichia coli and Synechocystis sp. strain PCC6803. Appl Environ Microbiol. 68, 4107–4110. doi:10.1128/AEM.68.8.4107-4110.2002 (2002).
Kornberg, A., Rao, N. N. & Ault-Riche, D. Inorganic polyphosphate: a molecule of many functions. Annu Rev Biochem. 68, 89–125. doi:10.1146/annurev.biochem.68.1.89 (1999).
Anand, A., Sato, M. & Aoyagi, H. Screening of Phosphate-accumulating Probiotics for Potential Use in Chronic Kidney Disorder. Food Science and Technology Research. 25, 89–96. doi:10.3136/fstr.25.89 (2019).
Liu, Q. et al. Surface components and metabolites of probiotics for regulation of intestinal epithelial barrier. Microb Cell Fact. 19, 23. doi:10.1186/s12934-020-1289-4 (2020).
Cinque, B. et al. Production Conditions Affect the In Vitro Anti-Tumoral Effects of a High Concentration Multi-Strain Probiotic Preparation. PLoS One. 11, e0163216. doi:10.1371/journal.pone.0163216 (2016).
Sanders, M. E. et al. Effects of genetic, processing, or product formulation changes on efficacy and safety of probiotics. Ann N Y Acad Sci. 1309, 1–18. doi:10.1111/nyas.12363 (2014).
Altschul, S. F., Gish, W., Miller, W., Myers, E. W. & Lipman, D. J. Basic local alignment search tool. J Mol Biol. 215, 403–410. 1990).
Gurr, E. The rational use of dyes in biology and general staining methods., xii + 422 pp. 1965).
Harold, F. M. Inorganic Polyphosphate of High Molecular Weight from Aerobacter Aerogenes. J Bacteriol. 86, 885–887. doi:10.1128/jb.86.4.885-887.1963 (1963).
Aschar-Sobbi, R. et al. High sensitivity, quantitative measurements of polyphosphate using a new DAPI-based approach. J Fluoresc. 18, 859–866. doi:10.1007/s10895-008-0315-4 (2008).
Savard, P. & Roy, D. Determination of Differentially Expressed Genes Involved in Arabinoxylan Degradation by Bifidobacterium longum NCC2705 Using Real-Time RT-PCR. Probiotics Antimicrob Proteins. 1, 121. doi:10.1007/s12602-009-9015-x (2009).
Zúñiga, M., Miralles, M. C. & Pérez-Martínez, G. The Product of arcR, the sixth gene of the arc operon of Lactobacillus sakei, is essential for expression of the arginine deiminase pathway. Appl Environ Microbiol. 68, 6051–6058. 2002).
Gómez-Gallego, C. et al. Breast Milk Polyamines and Microbiota Interactions: Impact of Mode of Delivery and Geographical Location. Annals of Nutrition and Metabolism. 70, 184–190. doi:10.1159/000457134 (2017).
Rodriguez-Viso, P. et al. Mercury toxic effects on the intestinal mucosa assayed on a bicameral in vitro model: Possible role of inflammatory response and oxidative stress. Food Chem Toxicol. 166, 113224. doi:10.1016/j.fct.2022.113224 (2022).
Jungersen, M. et al. The Science behind the Probiotic Strain Bifidobacterium animalis subsp. lactis BB-12®. Microorganisms. 2, 92–110. doi:10.3390/microorganisms2020092 (2014).
Peirotén, A., Arqués, J. L., Medina, M. & Rodríguez-Mínguez, E. Bifidobacterial strains shared by mother and child as source of probiotics. Beneficial Microbes. 9, 231–238. doi:10.3920/BM2017.0133 (2018).
Patole, S. K. et al. Benefits of bifidobacterium breve M-16V Supplementation in preterm neonates -A retrospective cohort study. PLoS ONE. 11, e0150775. doi:10.1371/journal.pone.0150775 (2016).
Whorwell, P. J. et al. Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome. American Journal of Gastroenterology. 101, 1581–1590. doi:10.1111/j.1572-0241.2006.00734.x (2006).
Wong, C. B., Odamaki, T. & Xiao, J. z. Beneficial effects of Bifidobacterium longum subsp. longum BB536 on human health: Modulation of gut microbiome as the principal action. Journal of Functional Foods. 54, 506–519. doi:10.1016/j.jff.2019.02.002 (2019).
Llamas-Arriba, M. G. et al. Heteropolysaccharide-producing bifidobacteria for the development of functional dairy products. Lwt. 102, 295–303. doi:10.1016/j.lwt.2018.12.044 (2019).
Capurso, L. Thirty Years of Lactobacillus rhamnosus GG: A Review. Journal of clinical gastroenterology. 53 Suppl 1, S1-S41. doi:10.1097/MCG.0000000000001170 (2019).
Ducrotté, P., Sawant, P. & Jayanthi, V. Clinical trial: Lactobacillus plantarum 299v (DSM 9843) improves symptoms of irritable bowel syndrome. World Journal of Gastroenterology. 18, 4012–4018. doi:10.3748/wjg.v18.i30.4012 (2012).
Sung, V. et al. Lactobacillus reuteri to treat infant colic: A meta-analysis. Pediatrics. 141. doi:10.1542/peds.2017-1811 (2018).
Kaźmierczak-Siedlecka, K., Ruszkowski, J., Fic, M., Folwarski, M. & Makarewicz, W. Saccharomyces boulardii CNCM I-745: A Non-bacterial Microorganism Used as Probiotic Agent in Supporting Treatment of Selected Diseases. Current microbiology. 77, 1987–1996. doi:10.1007/S00284-020-02053-9 (2020).

Competing interest reported. PH, TA, MP and JE-M are employees of AB-Biotics S.A. (part of KANEKA Corporation). The isolates described in this study are the subject of a pending patent application co-authored by MP and JE-M. The remaining authors have no conflict of interest to declare.

Download PDF

Journal Publication

published 08 Jul, 2023

Read the published version in Scientific Reports →

Editorial decision: Major revision
21 Mar, 2023
Reviews received at journal
03 Mar, 2023
Reviewers agreed at journal
27 Feb, 2023
Reviewers invited by journal
26 Feb, 2023
Editor assigned by journal
21 Feb, 2023
Editor invited by journal
29 Nov, 2022
Submission checks completed at journal
29 Nov, 2022
First submitted to journal
02 Nov, 2022

You are reading this latest preprint version

Study of the biosynthesis and functionality of polyphosphate in Bifidobacterium longum KABP042

Status:

Journal Publication

Version 1

Abstract

Figures

Introduction

Results

Discussion

Methods

Statistical analysis.

Declarations

References

Additional Declarations

Supplementary Files

Status:

Journal Publication

Version 1